To clarify the mechanism underlying MEG3-mediated degradation of P-STAT3, we treated cervical cancer cells with MG132 or 3-MA to block protein degradation via ubiquitination or autophagy, respectively, and performed western blot analysis to determine the difference in P-STAT3 expression among all the groups of cells. The gene discussed is MEG3; the disease is cervical cancer.